Drug-Drug Interactions:Inform the doctor if you are taking phenothiazine (thioridazine), anti-psychotic (lithium), antibiotic (linezolid, telithromycin, erythromycin, clarithromycin), an amino acid (tryptophan), pain killer (tramadol, ibuprofen, aspirin), anti-HIV (ritonavir, saquinavir, nelfinavir, atazanavir, amprenavir, fosamprenavir), anti-fungal (ketoconazole, itraconazole, fluconazole), anti-depressant (nefazodone), blood thinner (warfarin), impotent agents (sildenafil, tadalafil, vardenafil), calcium channel blocker (diltiazem, verapamil), anti-emetics (aprepitant), BPH agents and anti-migraine medicines.
Drug-Food Interactions:Do not take St. John’s wort (herbal supplement used to treat depression) while taking Dapoxetine. Avoid consuming grapefruit juice within 24 hours of taking Dapoxetine as it could lead to an increase in the level of Dapoxetine in the body.
Drug-Disease Interactions:Inform the doctor if you have cardiovascular/heart disease, a history of dizziness due to low blood pressure, depression, mania, bipolar disorder, schizophrenia, epilepsy/fits, bleeding or blood clotting problems, glaucoma, kidney problems, or moderate to severe liver problems.
Open issue:Dapoxetine is not an aphrodisiac and should not be taken during pregnancy or if breastfeeding. Always consult your doctor before starting St. John's wort (herbal supplement used to treat depression) while taking Dapoxetine.Selectivasis a registered clinical trial organization in the United States (the) that offers educational and research-based programs to help treat sexual and mental health conditions such as depression, anxiety disorders, and Parkinson's disease. For more information, contact the contact address below.
Selectia () is a member of the selective serotonin reuptake inhibitor (SSRI) drug-drug pairings group. This select group is part of a new class of medications called SSRIs, also called CYP2C, CYP3A4, CYP2D, CYP2D6, CYP2D6 inhibitors, or SNRIs. Selectivas is investigating whether SSRIs can reduce the severity of sexual and mental health conditions by improving the balance of re-uptake and thus sexual desire.References1. Semenyst Provides Research Support & Personal Consultation: Our Outpatient Program & Clinical Evaluation: Clinical Programs. Accessed September 12, 2023.
2. Drug-Drug Interactions: St John's wort, Herbal Supplements, and Grapefruit Juice.
SelectiaSelectivas is an educational center with more than 2,000 faculty and staff, and approximately 250 faculty members. Through the program, you will receive more than 700 faculty and staff presentations, and more than 300 faculty members in clinical expertise and experience. The program provides free, confidential, and flexible access to educational resources for all ages. Through our program, you will get the support, expertise, and experience you need to provide safe, effective, and compassionate care to people who may face the challenges of depression and anxiety disorder.
Selectivas is a registered professional association representing a range of medical and nonmedical healthcare providers. Through the educational program and clinical evaluation, you will learn more about the role of theSelectivas educational center in providing safe, effective, and compassionate care to people with depression and anxiety disorders, and about the potential role of theSelectivas educational center in providing safe, effective, and compassionate care to people who may face the challenges of depression and anxiety disorders. Through the educational program and clinical evaluation, you will learn more about the role of theSelectivas educational center in providing safe, effective, and compassionate care to people with depression and anxiety disorders. Through the educational program and clinical evaluation, you will learn more about the role of theSelectivas educational center in providing safe, effective, and compassionate care to people who may face the challenges of depression and anxiety disorders.
Drug-Drug Interactions:Inform the doctor if you are taking phenothiazine (thioridazine), anti-psychotic (lithium), antibiotic (linezolid, telithromycin, erythromycin, clarithromycin), an amino acid (tryptophan), pain killer (tramadol, ibuprofen, aspirin), anti-HIV (ritonavir, saquinavir, nelfinavir, atazanavir, amprenavir, fosamprenavir), anti-fungal (ketoconazole, itraconazole, fluconazole), anti-depressant (nefazodone), blood thinner (warfarin), impotent agents (sildenafil, tadalafil, vardenafil), calcium channel blocker (diltiazem, verapamil), anti-emetics (aprepitant), BPH agents and anti-migraine medicines.
Drug-Food Interactions:Do not take St. John’s wort (herbal supplement used to treat depression) while taking Dapoxetine. Avoid consuming grapefruit juice within 24 hours of taking Dapoxetine as it could lead to an increase in the level of Dapoxetine in the body.
Drug-Disease Interactions:Inform the doctor if you have cardiovascular/heart disease, a history of dizziness due to low blood pressure, depression, mania, bipolar disorder, schizophrenia, epilepsy/fits, bleeding or blood clotting problems, glaucoma, kidney problems, or moderate to severe liver problems.
Take special care withtaking St. John’s wortTake special care with taking St. John’s wort. St. John’s wort may make it more difficult for the stomach to absorb certain medications, such as St. John’s wortwort. Taking St. John’s wort with certain medications may also temporarily decrease the amount of tadalafil in the body.
Use St.John’s wort with certain medicationsExercise cautionExercise caution with taking St. Do not drink alcohol while taking St. Furthermore, if you experience any symptoms such as dizziness or drowsiness, contact your doctor immediately.
Phenothiazine (thioridazine) and anti-psychoticPhenothiazine and anti-psychotic interactions may occur with taking phenothiazine and antacids, vitamins/minerals, certain antibiotics, impneuming medicines (such as ciprofloxacin, erythromycin), migraine medicines (such as oculogyricum), and cardiac glycosides (such as amlodipine, diazepam, procainamide). These interactions may cause dizziness or drowsiness. Do not drive or operate heavy machinery until you know how the interactions affect you. If you experience any of the following symptoms while taking phenothiazine and anti-psychotic interactions: drowsiness; decreased concentration; lightheadedness; dizziness; balance problems; increased heart rate; get lightheaded (especially when standing) or get involved in scary or dangerous activities; do not follow any instructions or check with your doctor or pharmacist first: contact your doctor immediately if you have any of the following side effects: stomach pain, nausea, vomiting, loss of appetite, diarrhea, constipation, dizziness, or stomach discomfort; lightheadedness; stomach pain or cramps; nausea or vomiting; headache; stomach cramps; a fast or pounding heartbeat; feeling weak or tired; feeling confused, shaky, or unsteady (especially if you are standing or bent over); unusual vaginal bleeding or spotting; vaginal yeast infection (especially of the lower esophageal pressure)
Antacids and medicinesAntacids and medicines may temporarily decrease the amount of tadalafil in your body.
Viagra (sildenafil) is a medication primarily used for the treatment of erectile dysfunction (ED), which is a condition in which a man cannot achieve or maintain a penile erection sufficient for sexual intercourse. The primary objective of this study is to examine the effect of sildenafil on blood pressure (BP) in patients with ED, which is a common condition in Pakistan, and to determine the relationship between the dose of sildenafil and its impact on the BP. The study is a phase I study, and it will include three phases: a single-blind, placebo-controlled, and two-way cross-over study. After the phase I study, a prospective study is planned for a follow-up study, and it is the phase II study that will include three phases: a double-blind, placebo-controlled and two-way cross-over study. After the phase II study, the study will be conducted in two parts: a follow-up study in which sildenafil is administered in the first part of the study and a follow-up study in which the treatment is administered in the second part. The results of this study will be published in the peer-reviewed journalPharmacoepidemiolalia.
This study was conducted during September to October 2014 in two urban areas of Pakistan: one in Guzheria, and one in Peshawar. A total of 551 consecutive patients with ED were recruited from March to May 2015, and the study population consisted of 405 patients who met the inclusion criteria, and were willing to participate in the study. Patients who were not willing to take sildenafil or who had negative drug allergies were excluded. Patients who were diagnosed with any of the following diseases were excluded: heart failure, liver disease, hypertension, hypercholesterolemia, diabetes, diabetes mellitus, diabetes mellitus with the presence of organic diseases, hepatic, renal or intestinal disorders, and the presence of other cardiovascular diseases, including hypertension, and patients with significant hepatic dysfunction or severe liver dysfunction. Those who had a history of stroke, angina, or a family history of ischemic heart disease or heart failure were excluded. All the patients were given written informed consent before participating in the study. This study was registered at ClinicalTrials.gov as an Adverse Event Trial (NCT04979555).
This study was a double-blind, placebo-controlled, and two-way cross-over study, with three phases: a single-blind, placebo-controlled, and two-way cross-over study.
Patients with a BMI of ≥27 or <30 kg/m² and a history of ED at any time during the study, according to the International Classification of Diseases and the International Union Against it Disorders (U. D. I. D) or the World Health Organization, who are currently taking sildenafil or who have a family history of ED are eligible to participate in the study.
The study was conducted according to the guidelines of the ClinicalTrials.gov checklist. The study was approved by the Institutional Review Board of Faisalabad University, Pakistan, and it was written in English and informed by the ethics committee. Written informed consent was obtained from all the patients before participating in the study.
This study will be performed in two cities of Guzheria, Pakistan, and one of the cities in Peshawar.
The inclusion criteria of the study will be:
Patients with a BMI of ≥27 kg/m² and a history of ED at any time during the study, according to the International Classification of Diseases and the International Union against it Disorders (U.
Patients with a BMI of <27 kg/m² and a history of ED at any time during the study, according to the International Union against it Disorders (U.
Phosphodiesterase type 5 (PDE-5) inhibitors (selective inhibitors) are an important class of medications used to treat pulmonary hypertension. They work by blocking the actions of phosphodiesterase type 5, a group of enzymes responsible for breaking down the substance in the blood. This is especially important in the setting of coronary artery bypass graft (CABG) surgery and is associated with an increased risk of cardiovascular complications. These medications have been shown to have effects similar to that of sildenafil (Viagra), with some studies finding them to have fewer side effects. However, it is not always possible to determine if these medications are truly effective. This is why there are many different forms of medication available and why different types of medications have been approved by the FDA. It is important for patients to understand that these medications do not work for everyone, and that they do not increase the risk of heart problems or heart attacks. It is also important to be aware of the potential risks associated with using these medications.
It is important to note that there is no specific label information for all medications that is specific to each individual patient. It is always best to consult with a healthcare provider before starting any new medication. The FDA approves medications based on the information contained in the label and/or approved indications. It is always good to discuss medications with a healthcare provider to ensure they are safe and appropriate for the patient's condition.